Chris Rallis
Director/Board Member presso AEOLUS PHARMACEUTICALS, INC.
Patrimonio netto: 509 719 $ in data 31/03/2024
Profilo
Chris A.
Rallis is an Independent Director at Fennec Pharmaceuticals, Inc., Aeolus Pharmaceuticals, Inc., and Salisbury School, Inc. He was previously the President & Chief Executive Officer at ImmunoBiosciences, Inc. and President, Chief Operating Officer & Director at Triangle Pharmaceuticals, Inc. He also served as a Director at Incara Pharmaceuticals Corp.
and as VP-Strategic Planning & Business Development at Burroughs Wellcome.
Rallis holds a graduate degree from Duke University and an undergraduate degree from Harvard College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2024 | 45 838 ( 0.17% ) | 509 719 $ | 31/03/2024 |
Posizioni attive di Chris Rallis
| Società | Posizione | Inizio |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Director/Board Member | 01/06/2004 |
| FENNEC PHARMACEUTICALS INC. | Director/Board Member | 25/08/2011 |
| Salisbury School, Inc. | Director/Board Member | - |
Precedenti posizioni note di Chris Rallis
| Società | Posizione | Fine |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Director/Board Member | 10/06/2021 |
ImmunoBiosciences, Inc.
 ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Chief Executive Officer | 01/06/2007 |
| Incara Pharmaceuticals Corp. | Director/Board Member | 09/08/2004 |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | President | 01/01/2003 |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Chief Executive Officer | - |
Formazione di Chris Rallis
| Duke University | Graduate Degree |
| Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| FENNEC PHARMACEUTICALS INC. | Health Technology |
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
| Incara Pharmaceuticals Corp. | Health Technology |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Technology Services |
| Burroughs Wellcome | |
| Salisbury School, Inc. |
- Borsa valori
- Insiders
- Chris Rallis
